Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Pannus P, Depickère S, Kemlin D, Georges D, Houben S, Olislagers V, Waegemans A, De Craeye S, Francotte A, Chaumont F, Van Oostveldt C, Heyndrickx L, Michiels J, Willems E, Dhondt E, Krauchuk M, Schmickler MN, Verbrugghe M, Van Loon N, Dierick K, Matagne A, Desombere I, Ariën KK, Marchant A, Goossens ME. Pannus P, et al. Among authors: goossens me. Vaccine. 2023 Apr 24;41(17):2829-2836. doi: 10.1016/j.vaccine.2023.03.047. Epub 2023 Mar 27. Vaccine. 2023. PMID: 36997386 Free PMC article.
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Konnova A, De Winter FHR, Gupta A, Verbruggen L, Hotterbeekx A, Berkell M, Teuwen LA, Vanhoutte G, Peeters B, Raats S, der Massen IV, De Keersmaecker S, Debie Y, Huizing M, Pannus P, Neven KY, Ariën KK, Martens GA, Bulcke MVD, Roelant E, Desombere I, Anguille S, Berneman Z, Goossens ME, Goossens H, Malhotra-Kumar S, Tacconelli E, Vandamme T, Peeters M, van Dam P, Kumar-Singh S. Konnova A, et al. Among authors: goossens me. Front Immunol. 2022 Dec 22;13:1062136. doi: 10.3389/fimmu.2022.1062136. eCollection 2022. Front Immunol. 2022. PMID: 36618384 Free PMC article.
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Kemlin D, Gemander N, Depickère S, Olislagers V, Georges D, Waegemans A, Pannus P, Lemy A, Goossens ME, Desombere I, Michiels J, Vandevenne M, Heyndrickx L, Ariën KK, Matagne A, Ackerman ME, Le Moine A, Marchant A. Kemlin D, et al. Among authors: goossens me. Am J Transplant. 2023 May;23(5):649-658. doi: 10.1016/j.ajt.2023.02.015. Epub 2023 Feb 10. Am J Transplant. 2023. PMID: 36773936 Free PMC article.
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients.
Gemander N, Kemlin D, Depickère S, Kelkar NS, Pannus P, Sharma S, Waegemans A, Olislagers V, Georges D, Dhondt E, Braga M, Heyndrickx L, Michiels J, Thiriard A, Lemy A, Vandevenne M, Goossens ME, Matagne A, Desombere I, Ariën KK, Ackerman ME, Le Moine A, Marchant A. Gemander N, et al. Among authors: goossens me. Kidney Int Rep. 2023 Dec 20;9(3):635-648. doi: 10.1016/j.ekir.2023.12.008. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481503 Free PMC article.
Boosting capacity of a fourth dose BNT162b2 in cancer patients.
Debie Y, van Dam PA, Goossens ME, Peeters M, Vandamme T. Debie Y, et al. Among authors: goossens me. Eur J Cancer. 2023 Jan;179:121-123. doi: 10.1016/j.ejca.2022.11.016. Epub 2022 Nov 24. Eur J Cancer. 2023. PMID: 36521333 Free PMC article. No abstract available.
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.
Pannus P, Depickère S, Kemlin D, Houben S, Neven KY, Heyndrickx L, Michiels J, Willems E, De Craeye S, Francotte A, Chaumont F, Olislagers V, Waegemans A, Verbrugghe M, Schmickler MN, Van Gucht S, Dierick K, Marchant A, Desombere I, Ariën KK, Goossens ME. Pannus P, et al. Among authors: goossens me. PLOS Glob Public Health. 2022 Dec 20;2(12):e0001308. doi: 10.1371/journal.pgph.0001308. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962838 Free PMC article.
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.
Debie Y, Van Audenaerde JRM, Vandamme T, Croes L, Teuwen LA, Verbruggen L, Vanhoutte G, Marcq E, Verheggen L, Le Blon D, Peeters B, Goossens ME, Pannus P, Ariën KK, Anguille S, Janssens A, Prenen H, Smits ELJ, Vulsteke C, Lion E, Peeters M, van Dam PA. Debie Y, et al. Among authors: goossens me. Clin Cancer Res. 2023 Feb 1;29(3):635-646. doi: 10.1158/1078-0432.CCR-22-2185. Clin Cancer Res. 2023. PMID: 36341493
82 results